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Abstract
This study explored associations between health behaviors and human papillomavirus vaccine 
receipt/intentions among female undergraduates. Participants (N = 286) completed a survey 
assessing human papillomavirus vaccine uptake (receiving 1–3 shots vs no shots), completion 
(receiving 3 shots vs 1–2 shots), and intentions as well as various health behaviors. Human 
papillomavirus vaccine uptake and completion were associated with receipt of other preventive 
medical care; completion was associated with having a regular healthcare provider. Among 
unvaccinated students (n = 115), increased human papillomavirus vaccine intentions were 
associated with flu shot and human immunodeficiency virus test receipt. Findings suggest 
promoting human papillomavirus vaccination with other preventive medical care might improve 
vaccine receipt.
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Human papillomavirus (HPV) infections have been associated with increased risk of human 
immunodeficiency virus (HIV) and can result in genital warts, recurrent respiratory 
papillomatosis, and various cancers such as vulvar, vaginal, anal, and cervical cancers 
(Centers for Disease Control and Prevention, 2014). Spread by sexual contact, it is estimated 
that 79 million Americans are currently infected with at least one strain of HPV (Centers for 
Disease Control and Prevention, 2014). Currently, there are two HPV vaccines licensed by 
the Food and Drug Administration, Cervarix® and Gardasil®. These vaccines represent 
important steps in reducing cervical cancer incidence and mortality and are now routinely 
recommended for females aged 9–26 years (Centers for Disease Control and Prevention, 
2014).
Despite the benefits of HPV vaccination, a recent national survey found that only 45 percent 
of female undergraduate students had initiated the 3-shot vaccine series (Lindley et al., 
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2013). These findings are especially concerning given that women's cumulative incidence of 
a first-time HPV infection is approximately 32 percent within the first 2 years of college 
(Winer et al., 2003).
Previous studies with female undergraduates have examined demographic and psychosocial 
correlates of HPV vaccine receipt and intentions (Lindley et al., 2013; Ratanasiripong et al., 
2013); however, an important gap in the literature is the examination of their relationship to 
a range of protective and risky health behaviors. Identifying relationships between health 
behaviors will inform the development of interventions targeting multiple health behaviors 
(e.g. Moore et al., 2012). Thus, this study examined associations between various health 
behaviors (i.e. receipt of health care, such as vaccines and medical visits, physical activity, 
fruit and vegetable intake, smoking, and alcohol intake) and HPV vaccine uptake, 
completion, and intentions among female undergraduates.
Method
Participants and procedures
Following Institutional Review Board approval, female undergraduates were recruited from 
a psychology department research participant pool at a public Midwestern university in 
2012. Eligible students were fluent in English and between 18 and 32 years of age. This age 
group was selected because the HPV vaccine was approved in 2006 for females aged 13–26 
years (Brady et al., 2012). Thus, we were interested in recruiting participants for whom the 
HPV vaccine had been recommended.
After providing informed consent, students completed an anonymous password-protected 
online survey. The survey took place within a classroom in groups of up to 15 students 
spaced adequately such that privacy was protected. Following survey completion, a 
debriefing message was presented that included information regarding health services 
available on the campus. Students received course credit for their participation.
Measures
Demographics and medical history—Demographic information was collected and 
participants were asked whether they had been sexually active in the past 3 months (Penke, 
2011). Six items assessed personal history of HPV, an abnormal Pap smear, or cervical 
cancer as well as knowledge of someone with these conditions (Centers for Disease Control 
and Prevention, 2012).
HPV vaccine uptake, completion, and intentions—After reading a definition of the 
HPV vaccine, participants indicated whether they had received the vaccine (Brewer et al., 
2010). Those who had received the vaccine reported the number of shots they had received. 
Those who had not received any HPV shots were asked to report their HPV vaccine 
intentions (i.e. “How likely is it that you'll actually get the HPV vaccine?”; Gerend and 
Shepherd, 2012). Response options ranged from 1 (very unlikely) to 7 (very likely).
Health behaviors—Participants reported lifetime receipt of the hepatitis B vaccine, an 
HIV test, and a Pap smear as well as their receipt of a flu shot and a dental visit in the past 
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year (Centers for Disease Control and Prevention, 2012). Additionally, participants were 
asked whether there was a healthcare provider (i.e. doctor, nurse, or other health 
professional) that they saw most often (National Cancer Institute, 2012). Other health 
behaviors were assessed using well-validated and reliable measures, including items from 
the National College Health Assessment (NCHA) regarding average daily servings of fruits 
and vegetables and smoking status (Hoban, 2009), the Alcohol Use Disorders Identification 
Test (AUDIT) (Kokotailo et al., 2004), and the Godin Leisure-Time Exercise Questionnaire 
(LTEQ) (Godin and Shephard, 1997). The LTEQ provides a weekly physical activity score 
that corresponds to metabolic equivalent categories and values, including active, moderately 
active, and insufficiently active.
Statistical analyses
First, two HPV vaccine receipt variables were computed: HPV vaccine uptake (i.e. receiving 
1–3 shots vs no shots) and HPV vaccine completion (i.e. receiving all 3 shots vs 1–2 shots). 
Next, descriptive statistics were computed to characterize participants' demographic 
information, health behaviors, and HPV vaccine uptake, completion, and intentions. Then, 
chi-square analyses and an independent samples t-test were used to examine potential 
differences between those who were sexually active in the past 3 months and those who 
were not regarding HPV vaccine uptake, completion, and intentions. Next, logistic 
regression models estimated the unadjusted univariate effects of health behaviors on HPV 
vaccine uptake and completion. Subsequently, two multivariate logistic regression models 
estimated the adjusted effects of all health behaviors on HPV vaccine uptake and 
completion. Similarly, linear regression models estimated the unadjusted univariate effects 
of health behaviors on HPV intentions. Finally, a multivariate linear regression estimated the 
adjusted effects of all health behaviors on HPV vaccine intentions.
Results
Descriptive statistics
A total of 286 undergraduate women participated in the survey. Data from one participant 
who did not report HPV vaccine status were omitted from analyses. When examining HPV 
vaccine uptake and completion, data from all participants who completed relevant survey 
items were included in analyses (age range = 18–32 years). When examining HPV vaccine 
intentions, only data from students who had not received the HPV vaccine and were 26 years 
of age or younger were included in analyses (age range = 18–25 years), as the vaccine is 
currently approved for individuals between 9 and 26 years of age (Centers for Disease 
Control and Prevention, 2014).
In the full sample (n = 285), participants were, on average, 19 years old (standard deviation 
(SD) = 1.90 years). The majority were Caucasian (79.9%), heterosexual (95.1%), and single 
(91.8%). Most participants had health insurance (85.2%) and nearly two-thirds (65.7%) had 
been sexually active in the past 3 months. There were no differences between those who 
were sexually active and those who were not regarding HPV vaccine uptake, completion, or 
intentions (ps > .05). Concerning HPV vaccine uptake and completion, 57.5 percent 
(164/285) had received at least one HPV vaccine shot, and 72.6 percent (119/164) of those 
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who initiated vaccination completed the 3-shot series. Those who had not received any HPV 
vaccine shots (n = 115) reported an average vaccine intention score of 3.49 (SD = 2.01) on a 
7-point scale, indicating that they were “a little unlikely” to receive the HPV vaccine.
Concerning participants' medical history, most had never (1) received a diagnosis of HPV 
(96.5%) or known someone with this diagnosis (83.2%); (2) had an abnormal Pap smear 
(91.5%) or known someone with an abnormal Pap smear (71.2%); or (3) had a family 
history of cervical cancer (86.3%). Additionally, none of the participants had been diagnosed 
with cervical cancer. Concerning participants' receipt of health care, the majority had not 
received medical tests and vaccines in their lifetime, including an HIV test (77.0%), a Pap 
smear (61.3%), and the hepatitis B vaccine (53.4%), and most (69.8%) had not received a flu 
shot in the past year. However, over half of participants (55.6%) reported having a regular 
healthcare provider, and 78.9 percent had a dental visit in the past year. In addition, most 
participants were non-smokers (90.8%), and the mean AUDIT score was 3.91 (SD = 4.47), 
suggesting that the average participant did not consume problematic levels of alcohol 
(Kokotailo et al., 2004). The average participant also reported an active lifestyle on the 
LTEQ (M = 31.66, SD = 21.94; Godin, 2011). Fruit and vegetable intake, however, was 
below recommended levels, with 65 percent eating an average of 1 to 2 servings of fruits and 
vegetables per day (U.S. Department of Agriculture and U.S. Department of Health and 
Human Services, 2010).
Associations of health behaviors with HPV vaccine uptake, completion, and intentions
Results of univariate and multivariate analyses appear in Table 1. In univariate logistic 
regression analyses, HPV vaccine uptake was significantly related to receiving one or more 
hepatitis B vaccine shots and a Pap smear. In a multivariate logistic regression, all 10 health 
behaviors correctly classified 60 percent of the sample with respect to HPV vaccine uptake; 
however, only the receipt of one or more hepatitis B vaccine shots and a Pap smear uniquely 
predicted this outcome. Next, in univariate logistic regression analyses, HPV vaccine 
completion was significantly related to having a regular health-care provider, receiving a flu 
shot in the past year, never receiving an HIV test, and visiting the dentist in the past year. In 
a multivariate logistic regression, the 10 health behaviors correctly classified 77 percent of 
the sample with respect to HPV vaccine completion; however, only having a regular 
healthcare provider, never receiving an HIV test, and visiting the dentist in the past year 
uniquely predicted this outcome. Univariate linear regression analyses also were conducted 
to examine whether health behaviors predicted HPV vaccine intentions among those who 
had not received any HPV vaccine shots (n = 115). Greater HPV vaccine intentions were 
only associated with the receipt of the flu shot in the past year and HIV testing. In a 
multivariate linear regression analysis with the 10 health behaviors, these two variables 
uniquely predicted greater HPV vaccine intentions, and all predictors accounted for 21 
percent of the variance in HPV vaccine intentions.
Discussion
This study is among the first to explore associations between HPV vaccine uptake, 
completion, and intentions and a range of protective and risky health behaviors among 
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female undergraduate students. Concerning HPV vaccine uptake, 58 percent of the sample 
had received at least one HPV vaccine shot; however, only 42 percent had completed the 3-
shot series. HPV vaccine uptake and completion were associated with receiving other 
preventive medical care; however, only HPV vaccine completion was associated with having 
a regular healthcare provider. Students with a regular healthcare provider may be more likely 
to receive and follow their provider's medical recommendations due to increased trust in the 
provider or other relationship factors. Consistent with this interpretation, previous studies 
with the general population have found a strong association between healthcare provider 
recommendation and HPV vaccine uptake (Rosenthal et al., 2011; Williams et al., 2013). 
Alternatively, the present findings may reflect an underlying personality trait, such as 
conscientiousness. That is, students who are more conscientious may be more likely to have 
a regular healthcare provider and follow medical advice.
Among those who had not received any HPV vaccine shots, mixed findings were obtained 
regarding the relationship between HPV vaccine intentions and the receipt of preventive 
medical care. Specifically, increased HPV vaccine intentions were associated with receiving 
the flu shot in the past year and HIV testing but were unrelated to the receipt of other 
services. It is notable that the flu shot and HIV testing are widely administered at non-
medical locations, whereas receiving other services assessed in this study typically requires 
travel to medical facilities. Thus, receiving convenient medical care might have decreased 
perceived barriers to health care, thereby increasing HPV vaccine intentions.
Regarding other health behaviors, HPV vaccine uptake, completion, and intentions were not 
related to exercise, fruit and vegetable intake, smoking, or alcohol intake. One potential 
explanation for these findings is that adhering to certain lifestyle recommendations (e.g. 
regular exercise) requires more effort than receiving preventive medical care, such as the 
HPV vaccine. In addition, the lack of associations between smoking status and alcohol 
intake and HPV vaccine uptake, completion, and intentions may be due to range restriction, 
with most participants being non-smokers and reporting low levels of alcohol intake. A 
paucity of research has explored associations between the use of common substances and 
HPV vaccine receipt, with one national survey of young women suggesting that non-
smokers were more likely than current smokers to complete the 3-shot vaccine series 
(Williams et al., 2013). Whether this finding would be replicated in a heterogeneous sample 
of female undergraduate students requires study. Also of note, those who completed the 
HPV vaccine series were less likely to have been tested for HIV compared to those who did 
not complete the vaccine series. This finding may be due to sampling error, given that only a 
subgroup of participants (n = 159) were included in this analysis. However, a previous study 
with undergraduate women found that 58 percent of those who had completed the HPV 
vaccine series falsely believed that HPV and HIV have similar effects on one's body (Dillard 
and Spear, 2010), suggesting that some may confuse the two diseases. Future studies should 
explore whether women who confuse HPV and HIV are less likely to be tested for HIV after 
completing the HPV vaccine series.
Finally, this study highlights the need for interventions targeting HPV vaccine uptake and 
completion. Previous interventions to promote HPV vaccine uptake have focused on 
providing information about the vaccine (e.g. Krawczyk et al., 2012). Based on the current 
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findings, future research should test the hypothesis that interventions on college campuses 
may improve HPV vaccine uptake and completion through concurrently promoting the 
receipt of several preventive medical services, such as Pap smears, vaccinations, and dental 
visits. In addition, interventions could target healthcare providers through electronic medical 
record prompts, thus reminding providers to recommend the HPV vaccine.
Limitations of this study should be noted. The sample consisted of primarily Caucasian 
undergraduate students from a Midwestern university. Additionally, this study focused on 
female undergraduates, given that the HPV vaccine has primarily been marketed to women 
and girls (Williams et al., 2013). Furthermore, data were collected via self-report measures 
on one occasion. Future studies should consider including objective measures of HPV 
vaccine receipt (e.g. medical chart review) and longitudinally examining predictors of HPV 
vaccine intentions and receipt in a more culturally diverse sample of both male and female 
undergraduates. Finally, studies may incorporate variables that might help explain the 
relationship between HPV vaccine receipt and the use of other preventive medical services, 
such as conscientiousness and trust in one's healthcare provider.
The current findings suggest that HPV vaccine uptake, completion, and intentions are related 
to the receipt of other preventive medical care among female undergraduate students. Future 
intervention trials may examine whether promotion of a range of preventive medical services 
leads to increased HPV vaccine uptake and completion in this population. In addition, 
interventions that prompt healthcare providers to offer the HPV vaccine warrant evaluation.
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ol
 in
ta
ke
 (A
U
D
IT
)c
0.
06
0.
04
1.
38
0.
09
0.
04
1.
90
W
ee
kl
y 
ex
er
ci
se
 (L
TE
Q)
d
−
0.
01
0.
01
−
0.
83
−
0.
01
0.
01
−
1.
27
Av
er
ag
e 
da
ily
 se
rv
in
gs
 o
f f
ru
its
 a
nd
 v
eg
et
ab
le
s
−
0.
22
0.
28
−
0.
78
0.
15
0.
30
0.
51
H
PV
,
 
hu
m
an
 p
ap
ill
om
av
iru
s.
a C
od
ed
 a
s 1
 =
 1
–3
 sh
ot
s; 
0 
= 
no
 sh
ot
s.
b C
od
ed
 a
s 1
 =
 y
es
; 0
 =
 n
o.
c A
U
D
IT
 =
 A
lc
oh
ol
 U
se
 D
iso
rd
er
s I
de
nt
ifi
ca
tio
n 
Te
st
. H
ig
he
r s
co
re
s i
nd
ic
at
e 
m
or
e 
dr
in
ki
ng
.
d L
TE
Q 
= L
eis
ure
 Ti
m
e 
Ex
er
ci
se
 Q
ue
sti
on
na
ire
. H
igh
er 
sco
res
 in
dic
ate
 a 
mo
re 
ac
tiv
e 
lif
es
ty
le
.
e C
od
ed
 a
s 1
 =
 3
 sh
ot
s; 
0 
= 
1–
2 
sh
ot
s.
f H
PV
 v
ac
ci
ne
 in
te
nt
io
ns
 w
er
e 
as
se
ss
ed
 w
ith
 th
e 
qu
es
tio
n 
“H
ow
 li
ke
ly
 is
 it
 th
at
 y
ou
'll
 a
ct
ua
lly
 g
et
 th
e 
H
PV
 v
ac
ci
ne
?”
 R
es
po
ns
e 
op
tio
ns
 ra
ng
ed
 fr
om
 1
 (v
er
y 
un
lik
el
y) 
to 
7 (
ve
ry
 li
ke
ly
).
*
p 
<
 0
.0
5.
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